MET

MetLife
D

MET

Arincen73/100B

MetLife income statement 1995–2026

82.29B USD over the last twelve months, and 77.08B USD in fiscal year 2025.

Revenue Operating income Net income

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
30 Sept 2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Revenue
82.29B77.08B69.94B67.71B67.97B63.37B67.89B69.62B67.94B62.31B60.53B
Revenue growth
+16.29%+10.22%+3.29%-0.38%+7.26%-6.66%-2.49%+2.47%+9.04%+2.94%-1.33%
Cost of revenue
58.24B49.06B50.94B50.42B49.03B46.53B52.42B53.43B52.04B48.85B46.57B
Gross profit
24.05B28.02B19.00B17.29B18.94B16.84B15.47B16.19B15.90B13.46B13.96B
Gross margin
29.23%36.36%27.17%25.53%27.86%26.57%22.79%23.25%23.40%21.61%23.06%
Selling, general and administrative
—0.005.99B6.18B5.86B5.76B5.78B6.55B6.46B6.72B6.87B
Operating expenses
17.10B23.36B13.38B15.13B12.57B8.32B8.54B9.39B9.59B9.93B9.67B
6.95B4.66B5.62B2.16B6.36B8.52B6.93B6.80B6.31B3.54B4.28B
Operating income growth
+41.10%-17.09%+160.04%-66.03%-25.29%+22.97%+1.94%+7.74%+78.37%-17.40%-24.24%
Operating margin
8.44%6.05%8.04%3.19%9.36%13.44%10.20%9.76%9.28%5.68%7.07%
Interest expense
1.11B1.06B1.04B1.05B938.00M920.00M913.00M955.00M1.12B1.13B1.16B
Other non-operating income
—0.000.000.000.000.000.000.000.000.000.00
Pretax income
6.66B4.66B5.62B2.16B6.36B8.52B6.93B6.80B6.31B3.54B4.28B
Income tax
1.49B1.26B1.18B560.00M1.06B1.64B1.51B886.00M1.18B-1.47B693.00M
Effective tax rate
22.38%26.99%20.95%25.90%16.69%19.28%21.78%13.04%18.69%-41.57%16.19%
5.13B3.38B4.43B1.58B5.28B6.86B5.41B5.90B5.12B4.01B850.00M
Net income growth
+33.48%-23.66%+180.48%-70.14%-22.92%+26.78%-8.34%+15.15%+27.76%+371.76%-84.18%
Net margin
6.23%4.38%6.33%2.33%7.77%10.82%7.96%8.47%7.54%6.44%1.40%
Basic shares
650.99M664.96M689.21M762.43M779.10M825.54M892.91M915.34M958.61M1.04B1.10B
Diluted shares
654.06M664.96M711.10M762.43M808.90M869.40M913.20M944.40M1.01B1.04B1.10B
Change in diluted shares
-4.13%-6.49%-6.73%-5.74%-6.96%-4.80%-3.30%-6.85%-2.84%-4.74%-2.91%
EPS (basic)
7.724.805.981.826.357.705.726.104.953.740.68
EPS (diluted)
7.664.805.941.816.307.655.686.064.913.740.67
EPS growth
+44.26%-19.19%+228.18%-71.27%-17.65%+34.68%-6.27%+23.42%+31.28%+458.21%-85.34%
Dividends per share
2.322.252.162.061.981.901.821.741.661.471.40
Dividend growth
+4.27%+4.29%+4.61%+4.04%+4.21%+4.40%+4.60%+4.82%+12.96%+4.69%+6.78%
EBITDA
7.77B6.48B7.37B3.93B7.98B10.13B8.46B8.38B8.06B5.46B6.09B
EBITDA margin
9.44%8.40%10.54%5.80%11.73%15.99%12.46%12.04%11.86%8.76%10.06%
EBIT
7.77B5.72B6.66B3.21B7.30B9.44B7.84B7.75B7.43B4.67B5.44B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Common questions about MetLife's income statement

Source: Financial Modeling Prep